Sonehara R

No ORCID on file · 8 papers in corpus · active 2021-2025

Study types

  • article 2
  • other 2
  • preprint 1
  • rct 1

Condition tags

  • endometriosis 6
  • infertility 4
  • dysmenorrhea 2
  • endometrioma 2
2025
Amelioration of polycystic ovarian morphology by Tokishakuyakusan in a PCOS rat model: association with bone morphogenetic protein 4.
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1649124

BackgroundPolycystic ovary syndrome (PCOS) is a common cause of irregular menstrual cycles and infertility. Current treatments primarily involve ovulation induction and sex steroid hormone therapy. Tokishakuyakusan (TSS) is a traditional Ja…

other 2025
A novel senotherapeutic strategy with azithromycin for preventing endometriosis progression
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01381-4

BACKGROUND: Endometriosis is an estrogen-dependent chronic inflammatory disease, however the mechanisms underlying inflammation remain unclear. Non-hormonal drugs that can prevent endometriosis progression and resolve endometriotic infertil…

2025
Susceptibility of Brca1(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer.
Cancer science ·doi:10.1111/cas.16412

BRCA1 is one of the causative genes for hereditary breast and ovarian cancer syndrome with a high risk of early-onset breast cancer. Whereas olaparib (OLA), an inhibitor of poly-ADP-ribose polymerase, has been applied as adjuvant therapy to…

other 2024
Serum-derived small extracellular vesicles as biomarkers for predicting pregnancy and delivery on assisted reproductive technology in patients with endometriosis
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1442684

INTRODUCTION: Endometriosis can cause of infertility, and evaluation methods for predicting clinical pregnancy outcomes are desired. Extracellular vesicles (EVs) exist in blood and it contains small non-coding RNAs (ncRNAs) that may reflect…

article 2023
Serum miRNA as a predictive biomarker for ovarian reserve after endometrioma-cystectomy
Reproductive biology ·doi:10.1016/j.repbio.2023.100821

Ovarian endometrioma (OE) is a common gynecological disease that is often treated with surgery and hormonal treatment. However, ovarian cystectomy can impair the ovarian reserve (OR). Previously, we showed that perioperative administration …

article 2022
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00924-3

Abstract Background Endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects 10% of women of reproductive age. Ovarian endometriosis (OE) is the most common lesion in endometriosis…

preprint 2021
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for Ovarian Endometriosis
·doi:10.21203/rs.3.rs-1062370/v1

Abstract Background Endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects 10% of women of reproductive age. Ovarian endometriosis (OE) is the most common lesion in endometriosis…

rct 2021
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00866-2

BACKGROUND: Ovarian endometrioma is a common gynecological disease that is often treated with surgery or hormonal treatment. Ovarian cystectomy, a surgical procedure for ovarian endometrioma, can result in impaired ovarian reserve. METHODS…